Carl L. G. Hansen, Chief Executive Officer at AbCellera Biologics Inc. (ABCL), sold 11,598,420 shares at $25.50 ($279.3M) on 2021-06-09, disclosed to the SEC on 2021-06-10.
Open-market sale of $279.3M ABCL by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.03 | 5,598,420 | $134.5M | 48.2% |
| 2 | $24.03 | 5,598,420 | $134.5M | 48.2% |
| 3 | $25.50 | 401,580 | $10.2M | 3.7% |
| Total | $24.08 avg | 11,598,420 | $279.3M | 100% |